The next big test is whether using Pluvicto can delay the advancement of prostate cancer enough to delay chemical castration, ...

To help address the impact of COPD on patients and communities, global healthcare companies Sanofi and Regeneron are working together to study the ripple effects of COPD and to help create a ...